Artificially created blood tested in Japan

Artificially created blood passes safety assessment in Japan

test banner under the title image

A team of Japanese researchers led by Professor Hiromi Sakai from Nara Medical University has assessed the safety of artificially created blood.

The importance of donor blood is hard to overestimate, as it is needed in various medical fields: from cancer treatment to helping victims of traffic accidents and other emergencies. Due to periodic shortages of certain blood types, scientists are increasingly turning to the development of artificial analogues.

Japanese scientists have developed a method for extracting hemoglobin from expired donor blood and placing it in a protective shell to create artificial blood cells. These cells do not contain viruses and do not have a blood type, making them universal.

It is important to note that such artificial blood can be stored for up to two years, while donor blood is suitable for use for no more than a month. Initial studies indicate the safety of the new product and the possibility of conducting clinical trials.

During clinical trials, volunteers will be injected with 100 to 400 milliliters of artificial blood. If no complications arise at the first stage, the study will be expanded, the publication Vokrug Sveta reports.